AI-Powered Market News

Tuesday, February 24, 2026

Pulse

01 GM Recalls Over 43,000 SUVs Due to Transmission Issue 02 FedEx Sues Trump Administration Over Tariff Refunds 03 Supreme Court Ruling Disrupts Trump's Tariff Strategy 04 Negative Bitcoin Funding Rate Signals Potential Short Squeeze

All Stories →

Menu

Bearish (-57.1)

Topic Intelligence: arcellx

Last updated: 2026-02-23 23:49:05 ET

Overall Topic Sentiment (Range Avg): Bullish 50.0

Mentions (24h)

3

vs prior 24h: +100.0%

Mentions (Range)

3

8 day range (Feb 16 - Feb 23)

Sentiment (Avg / Median)

0.5 / 0.5

Based on 3 articles in range

Sentiment Mix (Range)

67% 33% 0%

Coverage Z-Score

N/A

Insufficient data (min 10 days)

Coverage & Sentiment Over Time

Share of Voice % Sentiment

Top Sources

Sentiment Mix

67% Bullish

67% Bullish 33% Neutral 0% Bearish

Related: gilead partner cancer biggest moves premarket novo nordisk domino pizza posting largest belief treatment buyout heading toward record acquire therapy

Latest Articles on "arcellx" (Range)

Stocks making the biggest moves premarket: Arcellx, Novo Nordisk, Domino's Pizza and more

CNBC Finance • 11h ago

Stocks making the biggest moves premarket: Arcellx, Novo Nordisk, Domino's Pizza and more

These are the stocks posting the largest moves in premarket trading.

Neutral 1.0

Gilead shows its belief in its partner’s cancer treatment with a $7.8 billion buyout

Market Watch • 11h ago

Gilead shows its belief in its partner’s cancer treatment with a $7.8 billion buyout

Arcellx’s stock is heading toward a record after the $7.8 billion deal to be acquired by Gilead.

Neutral 0.0

Gilead to acquire cancer therapy developer Arcellx for up to $7.8 billion

CNBC Top Stories • 12h ago

Gilead to acquire cancer therapy developer Arcellx for up to $7.8 billion

Gilead Sciences said on Monday it ⁠will buy cancer therapy partner Arcellx for an implied equity value of $7.8 billion.

Neutral 0.5

Fraywire Market Portal, Breaking Metrics Newsletter, and Glideslope AI are designed for informational purposes only. The content provided across these platforms—including, but not limited to, stock and crypto watchlists, price tracking, trade tracking, sentiment analysis, and news articles—should not be construed as financial advice or research reports. Users are encouraged to conduct their own research and consult with qualified financial professionals before making any investment decisions. While we strive to ensure the accuracy, completeness, and reliability of the information provided, Fraywire, Breaking Metrics, and Glideslope AI make no guarantees or warranties regarding the content's validity. By using these platforms, you acknowledge and agree that you are solely responsible for your own investment decisions and actions. Fraywire, Breaking Metrics, and Glideslope AI shall not be held liable for any losses or damages resulting from the use of the information provided.

Get Connected

Fraywire & Glideslope AI are Breaking Metrics productions.
Contact the developer for advertising opportunities, questions, and more at roy@rmahd.com

○ Subscribe
○ Fraywire+
○ Glideslope AI
○ Blog
○ RMAHD
○ Merch!